Skip to content

Study on the application of low-opioid anesthesia strategy in accelerated recovery of elderly patients with gastrointestinal tumors

Study on the application of low-opioid anesthesia strategy in accelerated recovery of elderly patients with gastrointestinal tumors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090311
Enrollment
Unknown
Registered
2024-09-27
Start date
2024-04-26
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Experimental group:Esketamine+Sufentanil
Control group:Sufentanil

Sponsors

Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled for laparoscopic gastrointestinal surgery and are aged =60 years, with surgical types including laparoscopic gastrectomy, colectomy, and rectectomy for gastric, colon, and rectal cancer, respectively; 2.American Society of Anesthesiologists (ASA) classification I to III; 3. Consent to postoperative intravenous patient-controlled analgesia; 4. Body Mass Index (BMI) between 18 and 30 kg/m²; 5. Willingness to participate in the study and signing of an informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of chronic pain; 2. History of opioid or alcohol abuse; 3. Significant cognitive impairment already present before surgery; 4. Neurological disorders; 5. Patients with poorly controlled or untreated hypertension (resting systolic/diastolic blood pressure exceeding 180/100 mmHg); 6. Elevated intraocular pressure (glaucoma) or increased intracranial pressure; 7. Patients with untreated or inadequately treated hyperthyroidism; 8. Severe cardiopulmonary,liver and kidney dysfunction; 9. Severe visual impairment; 10. Lack of cooperation or communication ability; 11. Allergy to the active ingredients or excipients of the study medication.

Design outcomes

Primary

MeasureTime frame
The consumption of opioid drugs at 24h and 48h after surgery;

Secondary

MeasureTime frame
Postoperative quality of recovery ;Patient controlled intravenous analgesia (PCIA) press number;Resting and cough pain scores;Time to first postoperative gas and bowel movement;Incidence of delirium 3 days after surgery;Athens Insomnia Scale;Anesthesia-related complications;Intraoperative consumption of remifentanil;

Countries

China

Contacts

Public ContactJiang Peng

Affiliated Hospital of Jiangsu University

doctorjp@163.com+86 139 1455 6527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026